Wk 1-2: Pharmacokinetics, Pharmacodynamics, Pharmacogenomics Flashcards

1
Q

Affinity

A

Affinity: The attraction between a drug and a receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Allosteric site:

A

Allosteric site: A binding site for substrates not active in initiating a response; a substrate that binds to an allosteric site may induce a conformational change in the structure of the active site, rendering it more or less susceptible to response from a substrate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bioavailability (F):

A

Bioavailability (F): The fraction or percentage of a drug that reaches the systemic circulation.

F = quantity of drug reaching systemic circulation / quantity of drug administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Biotransformation:

A

Biotransformation: Metabolism or degradation of a drug from an active form to an inactive form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chirality:

A

Chirality: Special configuration or shape of a drug; most drugs exist in two shapes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clearance:

A

Clearance: Removal of a drug from the plasma or organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Downregulation:

A

Downregulation: Decreased availability of drug receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Enantiomer (also called isomer)

A

Enantiomer (also called isomer): A mirror-image spatial arrangement, or shape, of a drug that suits it for binding with a drug receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Enterohepatic recirculation:

A

Enterohepatic recirculation: The process by which a drug excreted in the bile flows into the gastrointestinal tract, where it is reabsorbed and returned to the general circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First-pass effect:

A

First-pass effect: The phenomenon by which a drug first passes through the liver where it may be degraded before distribution to the tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Half-life (t1⁄2):

A

Half-life (t1⁄2): The time required for half of a total drug amount to be eliminated from the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hepatic extraction ratio:

A

Hepatic extraction ratio: A comparison of the percentage of drug extracted and the percentage of drug remaining active after metabolism in the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ligand:

A

Ligand: Any chemical, endogenous or exogenous, that interacts with a receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacodynamics:

A

Pharmacodynamics: Processes through which drugs affect the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacokinetics:

A

Pharmacokinetics: Processes through which the body affects drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prodrug:

A

Prodrug: A drug that is transformed from an inactive parent drug into an active metabolite; in effect, a precursor to the active drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Receptor:

A

Receptor: The site of drug action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Second messenger:

A

Second messenger: A chemical produced intracellularly in response to a receptor signal; this second messenger initiates a change in the intracellular response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Therapeutic window:

A

Therapeutic window: The range of drug concentration in the blood between a minimally effective level and a toxic level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Threshold:

A

Threshold: The level below which a drug exerts little to no therapeutic effect and above which a drug produces a therapeutic effect at the site of action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Upregulation:

A

Upregulation: Increased availability of receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Volume of distribution (Vd):

A

Volume of distribution (Vd): The extent of distribution of a drug in the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

High hepatic extraction ratio = ___ oral bioavailability

A

High hepatic extraction ratio = low oral bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Low hepatic extraction ratio = ___ oral bioavailability

A

Low hepatic extraction ratio = high oral bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Drugs w/ low hepatic extraction ratio <30%

A
Barbiturates
diazepam
warfarin
theophylline
tolbutamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Drugs w/ high hepatic extraction ratio >70% include…

A

lidocaine
meperidine
imipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Apparent Volume of Distribution

A

Vd = Amt in body / Plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Name a drug that is not metabolized at all

A

gentamicin (Garamycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Prodrug allopurinol metabolizes into

A

oxypurinol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Prodrug codeine metabolizes into

A

morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Prodrug enalapril metabolizes into

A

enalaprilat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Prodrug prednisone metabolizes into

A

Prednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Prodrug valacyclovir metabolizes into

A

Acyclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

first-order kinetics

A

the actual amount of drug eliminated is proportional to the concentration of the drug (the more drug there is, the faster it is eliminated). This applies to most drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

zero-order kinetics

A

Fixed amounts of drugs, rather than a fractional proportion, are eliminated at a constant rate
Example: alcohol
This can be dangerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Pharmacodynamics refers to:

A

the set of processes by which drugs produce specific biochemical or physiologic changes in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Four types of receptors:

A

gated ion channels
transmembranous receptors
G protein– coupled receptors (GPCR)
intracellular receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Foods with tyramine (fermented cheese, wine…) should not be taken with _____ to avoid _______.

A

MAOIs, hypertensive crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Pharmacogenomics

A

Role of genetic variation in drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Genetics may account for ___ to ___ % of variability in drug disposition and effects.

A

20 to 95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Adverse Drug Related Events account for (% admissions, total deaths)…

A

3 to 10% of hospital admissions and prolonged hospital stays, and 100,000 deaths annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

___% DNA accounts for individual differences/variances in drug metabolism and response

A

0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Allele:

A

any of the alternative forms of a gene occurring at a specific location on specific chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Genotype:

A

internally coded, inheritable info in the organism; combination of 2 alleles at single locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Phenotype:

A

a measurable trait or characteristic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

SNP: Single nucleotide polymorphism…

A

Variation in a DNA sequence the occurs when single nucleotide (Adenine, Thymine, Cytosine, Guanine) differs among members of a population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Polymorphisms

A

DNA variants that occur within a specific population at a frequency rate higher than 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

The focus of pharmacogenomics are…

A

…SNPs/Polymorphisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Substrate:

A

A drug that binds to and is metabolized by an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Enzyme:

A

catalysts that cause oxidation, reduction or hydrolysis of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Enzyme Inducer:

A

molecule (drug) that speeds up the production of an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Enzyme Inhibitor:

A

molecule (drug) that slows down or inhibits the production of an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Inducer/Inhibitor can include

A

…the drug itself, a second drug, food (grapefruit juice, kale)…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Genetic variants effect proteins how?

A

Genetic variants translate into functional changes in proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

More than ___ families of drug metabolizing enzymes in humans

A

30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Pt without pseudocholinesterase will be unable to break down _______ and could face complications of _______ including ________ as a result.

A

succinylcholine, prolonged paralysis and apnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Common efflux protein

A

P-glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Transport proteins like P-glycoprotein are thought to be ______ against toxins in food, etc

A

Protective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

P-gp controls ATP-dependent _____ _____ of ______

A

cellular efflux of substrates, anticancer drugs, immunosuppressive drugs, and other meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

A LOW expression of gene for P-gp will result in…

A

…higher drug levels. Less P-gp = more drug in circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

P-gp associated with lower ___ drug concentrations

A

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Protease inhibitors for HIV (indinavir, nelfinavir, etc…) have ___ bioavailability due to P-glycoprotein

A

Variable or low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Pt’s with low expression of P-gp have ______ plasma concentrations of HIV antivirals

A

2-5 times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

P-gp is expressed in these places:

A

GI tract, CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

___% of drugs marketed in US metabolized by cytochrome 450 / CYP450

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

CYP450 inhibited by these types of foods

A

Grapefruit juice, charred foods, kale / cruciferous vegetables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

CYP450 highest levels in this organ _____ but also found in this organ ____

A

liver, GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

P-gp is found in ______ and also in ____ and _____

A

intestine (transfers back to intestine), also in liver and kidney (transfers to bile and urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

The drug ______ INHIBITS intestinal P-gp and renal P-gp, leading to ____ levels of digoxin

A

Quinidine; increases ABSORPTION of digoxin in intestine, and decreases ELIMINATION of digoxin at kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

The antibiotic drug ________ has this effect on P-gp, and digoxin.

A

Rifampin induces intestinal P-gp, decreases digoxin absorption, lowering serum concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Alcohol can _______ CYP enzymes leading to ____ serum levels of drug

A

inhibit, increase …(hypoglycemia in pt’s taking insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Metronidazole inhibits enzyme ______, which increases ____ and leads to ______-like reaction

A

inhibits aldehyde dihydrogenase
elevates acetaldehyde
causes disulfiram-like reaction (flushing, h/a, n/v, hypotension, blurred vision)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

SMOKING can _______ CYP enzymes leading to ________ metabolism and _______ levels of certain drugs

A

Smoking can increase CYP metabolism leading to decreased levels of diazepam, propooxyphene, chlorpromazine, amitryptaline, theophylline…

74
Q

Warfarin is metabolized mainly by CYP___

A

CYP2C9

75
Q

Warfarin tends to be poorly metabolized by ______ due to ________ of CYP2C19

A

Asians, due to poor expression of CYP2C19

76
Q

Variant alleles of CYP2C9 occur in ____% of white population, affecting warfarin metabolism

A

18%

77
Q

Warfarin response is also impacted by gene ______

A

VKORC1, which encodes synthesis of vit K

78
Q

Lecture slide shows that average required warfarin dose is highest for this population; lowest for this population

A

Highest doses for African-American; lowest doses for Asian-American

79
Q

Clopidogrel is this type of drug ______ which when metabolized by CYP____ results in its active metabolite

A

prodrug, CYP2C19

80
Q

Deficiency of CYP2C19 among clopidogrel patients can result in recurrent ______, and are most commonly seen among _______ (50%) and then _______ (33%)

A

….higher rates of recurrent CV events, Asians, African Americans

81
Q

CYP2C19*1 is the “wild type” which means ______

A

Normal enzyme activity

82
Q

CYP2C19*2 is predominantly carried by _______ and are considered ________, and when on Plavix, they face higher rates of _______

A

Asians, poor-metabolizers, higher recurrent rates of CV events

83
Q

Warfarin works when _______ inhibits VKORC1 which encodes synthesis of ______

A

S-warfarin

vitamin K

84
Q

S-warfarin is metabolized by _____

A

CYP2C9

85
Q

Mutations to CYP2C9 can lead to ______ in warfarin patients (CYP2C92, CYP2C93)

A

Bleeding, due to decreased metabolism of S-warfarin, higher serum levels of S-warfarin, subsequent lower levels of VKORC1, and decreased production of vit K and decreased coagulation activity.

86
Q

VKORC1 mutation known as “________” can lead to ______ and thus require lower doses of _______; common among _______

A

VKORC1 “A haptotype” inactivating mutation can lead to less VKORC1 and thus require lower doses of warfarin; common among _______

87
Q

Codeine is a _______ and requires ______ to convert to active form _____

A

Prodrug, requires CYP2D6 to convert to morphine

88
Q

CYP2D6 poor metabolizers can lead to _______ effect of codeine and ultra-rapid metabolizers can lead to ______ effect from taking codeine leading to symptoms related to ______

A

CYP2D6 poor metabolizers can lead to poor pain relief effects of codeine (since poor metabolism to morphine), and ultra-rapid metabolizers can lead to toxic effect from taking codeine due to rapid increase in morphine levels - respiratory depression / apnea

89
Q

Cough and cold medications are not recommended for use in children younger than ____.
Opioids (codeine etc) not recommended in children younger than ______.

A

18 years
6 years
warning for use of tramadol for tonsillectomy etc for ages 12-16.

90
Q

Anti-depressant treatments are successful in ____ (fraction) of patients, which can be related to ______ status of patients

A

2/3 patients, metabolizer status

91
Q

Poor-metabolizers of anti-depressants can have this electrolyte imbalance.

A

Hyponatremia, related to SSRs and tricyclic antidepressants

92
Q

Poor metabolizer may have _______ level of drug in system, with potential _______ problems

A

higher, toxicity

93
Q

Ultra-metabolizer may have _____ level of drug in system, and may be ______ to achieve therapeutic drug levels

A

lower; unable

94
Q

This drug _____ can interfere with Tamoxifen (BRCA cancer med) leading to cancer recurrence

A

Paxil (SSRI)

95
Q

New drug applications are required to be screened for KCNH2 blocking activity, which can lead to ________.

A

QTc-prolongation

96
Q

Variations to ________ receptors may lead to ________ effects of albuterol and beta-blockers like metoprolol

A

beta-adrenergic receptors; pronounced effects, or no effect at all

97
Q

Antidepressants of this type have more pharmacogenomic problems and drug response issues

A

tricyclic antidepressants (e.g. noritriptaline) vs SSRI

98
Q

Swedish and Middle-Eastern patients tend to be _________ metabolizers of CYP_____

A

Swedish and Middle-Eastern patients tend to be ultra-metabolizers of CYP2D6.

99
Q

SNF on gene TCL1A can cause side effects of patients taking ______ including symptoms of _______; implication is _______

A

Tamoxifen; joint pain, stiffness, myalgias, decreased bone density; decreased medication adherence

100
Q

Metformin can result in _____ side effects if pt has certain gene

A

GI side effects

101
Q

Therapeutic drug monitoring is common among the ___

A

narrow therapeutic drugs, like aminoglycosides (gentamicin, other -mycin drugs)

102
Q

Enteric coating medications dissolve in:

A

intestine

103
Q

Rectal drugs are limited by ____ but have less _____ effect than oral drugs

A

erratic absorption, less hepatic first-pass effect than oral

104
Q

Sublingual, buccal meds bypass ___ and have ____ onset

A

first-pass

rapid

105
Q

IV meds have toxicity related to

A

peak concentrations

106
Q

Inhalation meds have ____ onset

A

rapid

107
Q

Topical meds offer the benefit of ______

A

less systemic exposure

108
Q

Fick’s Law predicts

A

how well a drug will passively diffuse across a membrane

109
Q

Passive diffusion is most common, and is facilitated by

A

larger surface area
larger concentration gradient
higher permeability
lower membrane thickness

110
Q

P-glycoprotein is an example of ____

A

carrier mediated, active transport

111
Q

Non-ionized > less polar are…

A

more lipid soluble > crosses membrane

112
Q

Ionized > more polar are…

A

less lipid soluble > does not cross membrane

113
Q

Drug trapping: Weak base: ionized form predominates in

A

acidic environments (stomach)

114
Q

Drug trapping: Weak acid: ionized form predominates in

A

basic environments (urine)

115
Q

P-gp is an efflux transporter also known as

A

MDR1, ABCB1

116
Q

P-gp is ______ for substrate

A

nonselective

117
Q

P-gp serves a protective function such as

A

protecting fetus, blood brain barrier, etc

118
Q

P-gp is found here:

A

tumor, intestine, blood brain barrier, kidney, placenta…

119
Q

P-gp is inhibited by many drugs including:

A

Amiodarone, captopril, carvedilol, ketoconazole, quinidine, verapamil, grapefruit juice

120
Q

P-gp is induced by…

A

St Johns Wort
Tipranavir/ritonavir (HIV med)
Phenytoin
Carbamazepine

121
Q

Basic / alkaline drugs are absorbed in the…

A

…duodenum (alkaline environment, remain non-ionized, and able to pass membrane into portal circulation)

122
Q

Acidic drugs are absorbed in the…

A

…stomach (acidic environment, remain non-ionized, and able to pass membrane into portal circulaton)

123
Q

P-gp is inhibited by…

A

…grapefruit juice, cyclosporine, verapamil, amiodarone

124
Q

Distribution is

A

drug movement from systemic circulation to tissues

125
Q

Which organ has the highest normalized blood flow?

A

Kidneys (3333 ml/min/kg)

126
Q

Drug binding proteins include

A

albumin

alpha1-acid glycoprotein

127
Q

Plasma protein binding remains ______

A

constant

128
Q

Vd =

A

Amt drug in body / drug concentration (plasma)

129
Q

Smaller Vd will remain in _____

A

Vascular compartment (more hydrophilic, large molecule, high PPB…. aspirin

130
Q

Larger Vd will remain

A

outside of plasma compartment (More lipophilic, small molecule, low PPB) …fluoxetine

131
Q

Elimination =

A

removal of drug from body, includes metabolism and excretion

132
Q

Purpose of metabolism:

A

To facilitate excretion

133
Q

Metabolism phases: Phase 1 and 2

A
Phase 1 (makes molecule polar, oxidation, hydrolysis
Phase 2 (conjugation (glucuronide)
134
Q

CYP450 uses this type of metabolism:

A

Phase 1 (oxidation, more polar/H2O soluble molecule)

135
Q

Enzyme is a

A

catalyst

136
Q

Metabolites can be active, such as metabolites of

A

diazepam

137
Q

Metabolites can be toxic, such as with

A

hepatotoxic acetaminophen metabolite

138
Q

Pro-drugs are metabolized into their active form such as:

A

Fosphenytoin, capecitabine, enalopril, codeine

139
Q

CYP450 constitute _____% of drug metabolism

A

70-80%

140
Q

CYP INDUCERS include

A

Barbituates, rifampin, anti-seizure meds, dexamethasone, phenytoin, St Johns Wort, char-grilled meat, cigarette smoke

141
Q

CYP INHIBITORS include

A

Grapefruit juice, antiretrovirals, -azoles, SSRIs, PPIs, CCBs, -mycins

142
Q

A person who takes codeine who has a duplicate allele of CYP2D6 will be ____ and have ______ effect

A

ultra-metabolizer, increased morphine level

143
Q

Phenobarbitol is acidic, therefore administering sodium bicarb will ________

A

alkalinize the urine and trap the drug to excrete it in case of an overdose

144
Q

Alcohol follows _______ kinetics

A

Zero-order (constant amount over time)

145
Q

Half-life equation

A

Half-life = 0.693 x Vd / Cl

146
Q

Half life is prolonged by:

A

increase in Vd, OR by decrease in rate of clearance

147
Q

Zero-order elimination drugs have no true…

A

half-life

148
Q

Zero-order elimination drugs can have dangerous…

A

accumulation

149
Q

Zero-order drugs include…

A

alcohol, phenytoin

150
Q

After about 5 half-lives, _____

A

97% of drug is eliminated

151
Q

Steady-state =

A

equilibrium (rate in = rate out)

152
Q

Endogenous ligands are

A

…ligands produced in the body (not drugs).

153
Q

Intrinsic activity of a drug is…

A

…ability of a drug to activate a receptor

154
Q

ACEI utilize this kind of receptor

A

enzymes

155
Q

These drugs use intracellular receptors…

A

sex hormones, steroids

156
Q

These drugs use circulating protein receptors…

A

…anticoagulants

157
Q

Irreversible inhibitor example

A

Omeprazole (PPIs)

158
Q

Allosteric interactions

A

Drug attaches to binding site OTHER than the active site to change conformational form of receptor, changing effect (increasing or decreasing)

159
Q

Benzodiazepines are blocked by _____ which is a ______

A

Flumazenil, competitive antagonist, can reverse the binding of benzodiazepines

160
Q

cAMP and cGMP and Ca++ are…

A

…second messenger molecules in the transduction pathway that cause cellular response

161
Q

PDE5 inhibitors (sildenafil, etc) work at _____ level

A

second messenger, increasing cGMP response

162
Q

Quantal Dose-Effect Curve

A

Measures how a population responds to a drug

163
Q

________ Index = TD50 / ED50

A

Therapeutic Index = TD50 / ED50 (median toxic dose / median effective dose)

164
Q

On-target toxicity

A

Intended receptor (improper dose, same receptor but wrong tissue); these are “class effects”

165
Q

Off-target toxicity

A

Unintended target; enantiomers; binds different receptors; immune-related effects; binds different receptor sub-type

166
Q

Tachyphylaxis =

A

Tolerance

167
Q

PK related toxicity involves

A

CYP450, transporters, PPB related

168
Q

PD related toxicity

A

Method of action interaction (PDE5 inhibitor + NTG)

169
Q

Most frequent reason for drug withdrawal in US

A

hepatotoxicity

170
Q

Hepatic function impairment marker

A

Bilirubin

171
Q

Hepatocellular injury markers

A

AST, ALT, ALP

172
Q

Renal injury marker

A

Creatinine (drugs: NSAIDS, gentamicin)

173
Q

Pulmonary toxicity can be caused by…

A

amiodarone

174
Q

Gentamicin has a narrow therapeutic index and requires _______ monitoring, specifically ____ and ____ monitoring. It causes ______ toxicity.

A

Therapeutic Drug Monitoring
Peak (toxicity >10-12mcg/mL)
Trough (>2mcg/mL)
Renal toxicity

175
Q

NSAIDs can cause _______ toxicity

A

Renal

176
Q

Narrow therapeutic drugs include

A
warfarin
digoxin
gentamicin
lithium
phenytoin
carbamazepine
Cytotoxic drugs (including anti-epileptic and chemotherapy drugs)
177
Q

Drug distribution to various compartments (compartment / molecule type)

A

Total body water: small, hydrophilic (ethanol)
Extracellular water: Larger, hydrophilic (mannitol)
Blood plasma: Large, plasma-bound, ionized (heparin)
Adipose tissue: Lipophilic (diazepam)
Bone / teeth: Certain ions (fluoride, strontium)

178
Q

Higher Vd typically means ______ half-life due to ______ availability to organs of elimination

A

longer

decreased

179
Q

Vd and compartments:
Plasma compartment:
Extracellular fluid:
Total body water:

A

Plasma compartment:
Low Vd [4L/70kg] (large, protein bound)
heparin

Extracellular fluid:
Medium Vd [20% body wt] (small, hydrophilic) Aminoglycoside abx

Total body water:
High Vd [60% body wt, 42L/70kg] (small, lipophilic) ETHANOL, ASPIRIN

180
Q

Quinidine is metabolized by receptor ______ but works through noncompetitive inhibition to block receptor ________

A

CYP3A4

CYP2D6